| Catalog Number |
367292 |
| Medical Device Problem Code |
Leak/Splash (1354)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
11/27/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
It was reported that when using one (1) bd vacutainer® safety-lok¿ blood collection set, sleeve leakage occurred.No adverse impact was reported regarding the patient or user.
|
| |
|
Additional Manufacturer Narrative
|
|
The manufacturing location for this product is (nipro).This site is an oem manufacturing site.Therefore, bd corporate headquarters in franklin lakes, nj has been listed in sections d.3.And g.1.And the franklin lakes fda registration number has been used for the manufacture report number.A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
|
| |
|
Event or Problem Description
|
|
It was reported that when using one (1) bd vacutainer® safety-lok¿ blood collection set, sleeve leakage occurred.No adverse impact was reported regarding the patient or user.
|
| |
|
Additional Manufacturer Narrative
|
|
Investigation summary: bd had not received samples, but one photo was provided for investigation.The photo was reviewed and the indicated failure mode for sleeve leakage was observed.Additionally, 50 retention samples from bd inventory were evaluated by visual examination and the issue of sleeve leakage was not observed.Also, 8 retention samples from bd inventory were evaluated by functional testing and the issue of sleeve leakage was not observed.Based on a review of the device history record for the incident lot, all product specifications and requirements for lot release were met.There were no related quality issues during manufacturing of the product.This complaint has been confirmed for the indicated failure mode sleeve leakage.Bd was not able to identify a root cause for the indicated failure mode.Complaints received for this device and reported condition will continue to be tracked and trended.Our business team regularly reviews the collected data for identification of emerging trends.
|
| |
|
Search Alerts/Recalls
|